Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery

scientific article published on 9 December 2012

Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00540-012-1537-9
P698PubMed publication ID23223915
P5875ResearchGate publication ID233886492

P2093author name stringMohamed A Khalil
Abdelhay A Ebade
Ahmed K Mohamed
P2860cites workEffects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studiesQ28249459
Myocardial efficiency during levosimendan infusion in congestive heart failure.Q31647357
Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertensionQ35961813
Management strategies for patients with pulmonary hypertension in the intensive care unitQ36940493
Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies.Q37717988
Levosimendan in the treatment of cardiogenic shock.Q37799518
Pulmonary vascular disease with congenital heart lesions: pathologic features and causesQ39566087
Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventionsQ42746134
Use of levosimendan in cardiosurgical patients with chronic heart insufficiencyQ43044437
Acute hemodynamic effects of inhaled nitroglycerine, intravenous nitroglycerine, and their combination with intravenous dobutamine in patients with secondary pulmonary hypertensionQ43074088
Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients.Q43283968
Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.Q44297394
Successful treatment of dilative cardiomyopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist supportQ45224330
Weaning difficult-to-wean chronic obstructive pulmonary disease patients: a pilot study comparing initial hemodynamic effects of levosimendan and dobutamineQ46187787
Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients.Q46422969
Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery.Q48273297
Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardiumQ48750045
Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.Q51027720
Levosimendan in Congenital Cardiac Surgery: A Randomized, Double-Blind Clinical TrialQ51752502
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.Q53901244
Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes.Q53965064
Are transoesophageal Doppler parameters a reliable guide to paediatric haemodynamic status and fluid management?Q54014530
Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.Q54137481
Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.Q54167403
Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers*Q57623335
Levosimendan attenuates pulmonary vascular remodelingQ60722882
Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopyQ69668980
Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case seriesQ80295708
P433issue3
P921main subjectpulmonary hypertensionQ1128595
P304page(s)334-339
P577publication date2012-12-09
P1433published inJournal of AnesthesiaQ2308373
P1476titleLevosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery
P478volume27

Reverse relations

cites work (P2860)
Q102209087An evidence-based review of the use of vasoactive and inotropic medications in post-operative paediatric patients after cardiac surgery with cardiopulmonary bypass from 2000 to 2020
Q38588160Critical care for paediatric patients with heart failure
Q97884755Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Q58781484Levosimendan for Pediatric Anomalous Left Coronary Artery From the Pulmonary Artery Undergoing Repair: A Single-Center Experience
Q51760678Levosimendan for Perioperative Cardioprotection: Myth or Reality?
Q89443434Levosimendan in pulmonary hypertension and right heart failure
Q24629274Levosimendan: current data, clinical use and future development
Q57689718Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease
Q38644872Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Q48380637The Perspective of the Intensivist on Inotropes and Postoperative Care Following Pediatric Heart Surgery: An International Survey and Systematic Review of the Literature
Q47237484Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice.